23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      International Society of Sports Nutrition Position Stand: Probiotics

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Position statement: The International Society of Sports Nutrition (ISSN) provides an objective and critical review of the mechanisms and use of probiotic supplementation to optimize the health, performance, and recovery of athletes. Based on the current available literature, the conclusions of the ISSN are as follows:

          1. Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host (FAO/WHO).

          2. Probiotic administration has been linked to a multitude of health benefits, with gut and immune health being the most researched applications.

          3. Despite the existence of shared, core mechanisms for probiotic function, health benefits of probiotics are strain- and dose-dependent.

          4. Athletes have varying gut microbiota compositions that appear to reflect the activity level of the host in comparison to sedentary people, with the differences linked primarily to the volume of exercise and amount of protein consumption. Whether differences in gut microbiota composition affect probiotic efficacy is unknown.

          5. The main function of the gut is to digest food and absorb nutrients. In athletic populations, certain probiotics strains can increase absorption of key nutrients such as amino acids from protein, and affect the pharmacology and physiological properties of multiple food components.

          6. Immune depression in athletes worsens with excessive training load, psychological stress, disturbed sleep, and environmental extremes, all of which can contribute to an increased risk of respiratory tract infections. In certain situations, including exposure to crowds, foreign travel and poor hygiene at home, and training or competition venues, athletes’ exposure to pathogens may be elevated leading to increased rates of infections. Approximately 70% of the immune system is located in the gut and probiotic supplementation has been shown to promote a healthy immune response. In an athletic population, specific probiotic strains can reduce the number of episodes, severity and duration of upper respiratory tract infections.

          7. Intense, prolonged exercise, especially in the heat, has been shown to increase gut permeability which potentially can result in systemic toxemia. Specific probiotic strains can improve the integrity of the gut-barrier function in athletes.

          8. Administration of selected anti-inflammatory probiotic strains have been linked to improved recovery from muscle-damaging exercise.

          9. The minimal effective dose and method of administration (potency per serving, single vs. split dose, delivery form) of a specific probiotic strain depends on validation studies for this particular strain. Products that contain probiotics must include the genus, species, and strain of each live microorganism on its label as well as the total estimated quantity of each probiotic strain at the end of the product’s shelf life, as measured by colony forming units (CFU) or live cells.

          10. Preclinical and early human research has shown potential probiotic benefits relevant to an athletic population that include improved body composition and lean body mass, normalizing age-related declines in testosterone levels, reductions in cortisol levels indicating improved responses to a physical or mental stressor, reduction of exercise-induced lactate, and increased neurotransmitter synthesis, cognition and mood. However, these potential benefits require validation in more rigorous human studies and in an athletic population.

          Related collections

          Most cited references220

          • Record: found
          • Abstract: found
          • Article: not found

          Bacteriocins: developing innate immunity for food.

          Bacteriocins are bacterially produced antimicrobial peptides with narrow or broad host ranges. Many bacteriocins are produced by food-grade lactic acid bacteria, a phenomenon which offers food scientists the possibility of directing or preventing the development of specific bacterial species in food. This can be particularly useful in preservation or food safety applications, but also has implications for the development of desirable flora in fermented food. In this sense, bacteriocins can be used to confer a rudimentary form of innate immunity to foodstuffs, helping processors extend their control over the food flora long after manufacture.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress

            The mucus layer coating the gastrointestinal tract is the front line of innate host defense, largely because of the secretory products of intestinal goblet cells. Goblet cells synthesize secretory mucin glycoproteins (MUC2) and bioactive molecules such as epithelial membrane-bound mucins (MUC1, MUC3, MUC17), trefoil factor peptides (TFF), resistin-like molecule β (RELMβ), and Fc-γ binding protein (Fcgbp). The MUC2 mucin protein forms trimers by disulfide bonding in cysteine-rich amino terminal von Willebrand factor (vWF) domains, coupled with crosslinking provided by TFF and Fcgbp proteins with MUC2 vWF domains, resulting in a highly viscous extracellular layer. Colonization by commensal intestinal microbiota is limited to an outer “loose” mucus layer, and interacts with the diverse oligosaccharides of mucin glycoproteins, whereas an “inner” adherent mucus layer is largely devoid of bacteria. Defective mucus layers resulting from lack of MUC2 mucin, mutated Muc2 mucin vWF domains, or from deletion of core mucin glycosyltransferase enzymes in mice result in increased bacterial adhesion to the surface epithelium, increased intestinal permeability, and enhanced susceptibility to colitis caused by dextran sodium sulfate. Changes in mucin gene expression and mucin glycan structures occur in cancers of the intestine, contributing to diverse biologic properties involved in the development and progression of cancer. Further research is needed on identification and functional significance of various components of mucus layers and the complex interactions among mucus layers, microbiota, epithelial cells, and the underlying innate and adaptive immunity. Further elucidation of the regulatory mechanisms involved in mucin changes in cancer and inflammation may lead to the development of novel therapeutic approaches.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Position statement. Part one: Immune function and exercise.

              An ever-growing volume of peer-reviewed publications speaks to the recent and rapid growth in both scope and understanding of exercise immunology. Indeed, more than 95% of all peer-reviewed publications in exercise immunology (currently >2, 200 publications using search terms "exercise" and "immune") have been published since the formation of the International Society of Exercise and Immunology (ISEI) in 1989 (ISI Web of Knowledge). We recognise the epidemiological distinction between the generic term "physical activity" and the specific category of "exercise", which implies activity for a specific purpose such as improvement of physical condition or competition. Extreme physical activity of any type may have implications for the immune system. However, because of its emotive component, exercise is likely to have a larger effect, and to date the great majority of our knowledge on this subject comes from exercise studies. In this position statement, a panel of world-leading experts provides a consensus of current knowledge, briefly covering the background, explaining what we think we know with some degree of certainty, exploring continued controversies, and pointing to likely directions for future research. Part one of this position statement focuses on 'immune function and exercise' and part two on 'maintaining immune health'. Part one provides a brief introduction and history (Roy Shephard) followed by sections on: respiratory infections and exercise (Maree Gleeson); cellular innate immune function and exercise (Jeffrey Woods); acquired immunity and exercise (Nicolette Bishop); mucosal immunity and exercise (Michael Gleeson and Nicolette Bishop); immunological methods in exercise immunology (Monika Fleshner); anti-inflammatory effects of physical activity (Charlotte Green and Bente Pedersen); exercise and cancer (Laurie Hoffman-Goetz and Connie Rogers) and finally, "omics" in exercise (Hinnak Northoff, Asghar Abbasi and Perikles Simon). The focus on respiratory infections in exercise has been stimulated by the commonly held beliefs that the frequency of upper respiratory tract infections (URTI) is increased in elite endurance athletes after single bouts of ultra-endurance exercise and during periods of intensive training. The evidence to support these concepts is inconclusive, but supports the idea that exercised-induced immune suppression increases susceptibility to symptoms of infection, particularly around the time of competition, and that upper respiratory symptoms are associated with performance decrements. Conclusions from the debate on whether sore throats are actually caused by infections or are a reflection of other inflammatory stimuli associated with exercise remains unclear. It is widely accepted that acute and chronic exercise alter the number and function of circulating cells of the innate immune system (e.g. neutrophils, monocytes and natural killer (NK) cells). A limited number of animal studies has helped us determine the extent to which these changes alter susceptibility to herpes simplex and influenza virus infection. Unfortunately, we have only 'scratched the surface' regarding whether exercise-induced changes in innate immune function alter infectious disease susceptibility or outcome and whether the purported anti-inflammatory effect of regular exercise is mediated through exercise-induced effects on innate immune cells. We need to know whether exercise alters migration of innate cells and whether this alters disease susceptibility. Although studies in humans have shed light on monocytes, these cells are relatively immature and may not reflect the effects of exercise on fully differentiated tissue macrophages. Currently, there is very little information on the effects of exercise on dendritic cells, which is unfortunate given the powerful influence of these cells in the initiation of immune responses. It is agreed that a lymphocytosis is observed during and immediately after exercise, proportional to exercise intensity and duration, with numbers of cells (T cells and to a lesser extent B cells) falling below pre-exercise levels during the early stages of recovery, before returning to resting values normally within 24 h. Mobilization of T and B cell subsets in this way is largely influenced by the actions of catecholamines. Evidence indicates that acute exercise stimulates T cell subset activation in vivo and in response to mitogen- and antigen-stimulation. Although numerous studies report decreased mitogen- and antigen-stimulated T cell proliferation following acute exercise, the interpretation of these findings may be confounded by alterations in the relative proportion of cells (e.g. T, B and NK cells) in the circulation that can respond to stimulation. Longitudinal training studies in previously sedentary people have failed to show marked changes in T and B cell functions provided that blood samples were taken at least 24 h after the last exercise bout. In contrast, T and B cell functions appear to be sensitive to increases in training load in well-trained athletes, with decreases in circulating numbers of Type 1 T cells, reduced T cell proliferative responses and falls in stimulated B cell Ig synthesis. The cause of this apparent depression in acquired immunity appears to be related to elevated circulating stress hormones, and alterations in the pro/anti-inflammatory cytokine balance in response to exercise. The clinical significance of these changes in acquired immunity with acute exercise and training remains unknown. The production of secretory immunoglobulin A (SIgA) is the major effector function of the mucosal immune system providing the 'first line of defence' against pathogens. To date, the majority of exercise studies have assessed saliva SIgA as a marker of mucosal immunity, but more recently the importance of other antimicrobial proteins in saliva (e.g. alpha-amylase, lactoferrin and lysozyme) has gained greater recognition. Acute bouts of moderate exercise have little impact on mucosal immunity but prolonged exercise and intensified training can evoke decreases in saliva secretion of SIgA. Mechanisms underlying the alterations in mucosal immunity with acute exercise are probably largely related to the activation of the sympathetic nervous system and its associated effects on salivary protein exocytosis and IgA transcytosis. Depressed secretion of SIgA into saliva during periods of intensified training and chronic stress are likely linked to altered activity of the hypothalamic-pituitary-adrenal axis, with inhibitory effects on IgA synthesis and/or transcytosis. Consensus exists that reduced levels of saliva SIgA are associated with increased risk of URTI during heavy training. An important question for exercise immunologists remains: how does one measure immune function in a meaningful way? One approach to assessing immune function that extends beyond blood or salivary measures involves challenging study participants with antigenic stimuli and assessing relevant antigen-driven responses including antigen specific cell-mediated delayed type hypersensitivity responses, or circulating antibody responses. Investigators can inject novel antigens such as keyhole limpet haemocyanin (KLH) to assess development of a primary antibody response (albeit only once) or previously seen antigens such as influenza, where the subsequent antibody response reflects a somewhat more variable mixture of primary, secondary and tertiary responses. Using a novel antigen has the advantage that the investigator can identify the effects of exercise stress on the unique cellular events required for a primary response that using a previously seen antigen (e.g. influenza) does not permit. The results of exercise studies using these approaches indicate that an acute bout of intense exercise suppresses antibody production (e.g. anti-KLH Ig) whereas moderate exercise training can restore optimal antibody responses in the face of stressors and ageing. Because immune function is critical to host survival, the system has evolved a large safety net and redundancy such that it is difficult to determine how much immune function must be lost or gained to reveal changes in host disease susceptibility. There are numerous examples where exercise alters measures of immunity by 15-25%. Whether changes of this magnitude are sufficient to alter host defence, disease susceptibility or severity remains debatable. Chronic inflammation is involved in the pathogenesis of insulin resistance, atherosclerosis, neurodegeneration, and tumour growth. Evidence suggests that the prophylactic effect of exercise may, to some extent, be ascribed to the anti-inflammatory effect of regular exercise mediated via a reduction in visceral fat mass and/or by induction of an anti-inflammatory environment with each bout of exercise (e.g. via increases in circulating anti-inflammatory cytokines including interleukin (IL)-1 receptor antagonist and IL-10). To understand the mechanism(s) of the protective, anti-inflammatory effect of exercise fully, we need to focus on the nature of exercise that is most efficient at allieviating the effects of chronic inflammation in disease. The beneficial effects of endurance exercise are well known; however, the antiinflammatory role of strength training exercises are poorly defined. In addition, the independent contribution of an exercise-induced reduction in visceral fat versus other exercise-induced anti-inflammatory mechanisms needs to be understood better. There is consensus that exercise training protects against some types of cancers. Training also enhances aspects of anti-tumour immunity and reduces inflammatory mediators. However, the evidence linking immunological and inflammatory mechanisms, physical activity, and cancer risk reduction remains tentative. (ABSTRACT TRUNCATED)
                Bookmark

                Author and article information

                Contributors
                ralf.jaeger@increnovo.com
                aemohr@asu.edu
                katie.carpenter@isagenixcorp.com
                ckerksick@lindenwood.edu
                martin.purpura@increnovo.com
                a_mous01@uni-muenster.de
                jrtownsend@lipscomb.edu
                manfred.lamprecht@medunigraz.at
                n.west@griffith.edu.au
                katherine.black@otago.ac.nz
                m.gleeson@lboro.ac.uk
                david.pyne@canberra.edu.au
                shawn@worldsgreatestingredients.com
                sarent@mailbox.sc.edu
                abbsmith@email.unc.edu
                rbkreider@tamu.edu
                bcampbell@usf.edu
                laurent@theiopn.com
                jonathan.scheiman@fitbiomics.com
                cwissent@jamiesonlabs.com
                m.pane@probiotical.com
                dkalman@nutrasource.ca
                J.Pugh@ljmu.ac.uk
                jessica@internationalprobiotics.org
                exphys@aol.com
                Journal
                J Int Soc Sports Nutr
                J Int Soc Sports Nutr
                Journal of the International Society of Sports Nutrition
                BioMed Central (London )
                1550-2783
                21 December 2019
                21 December 2019
                2019
                : 16
                : 62
                Affiliations
                [1 ]Increnovo LLC, Milwaukee, WI USA
                [2 ]ISNI 0000 0001 2151 2636, GRID grid.215654.1, College of Health Solutions, Arizona State University, ; Phoenix, AZ USA
                [3 ]Isagenix International LLC, Gilbert, AZ USA
                [4 ]ISNI 0000 0000 8539 0749, GRID grid.431378.a, Exercise and Performance Nutrition Laboratory, School of Health Sciences, , Lindenwood University, ; St. Charles, MO USA
                [5 ]University of Münster, Department of Physics Education, Münster, Germany
                [6 ]ISNI 0000 0001 0225 7385, GRID grid.440609.f, Exercise and Nutrition Science Graduate Program, , Lipscomb University, ; Nashville, TN USA
                [7 ]ISNI 0000 0000 8988 2476, GRID grid.11598.34, Otto Loewi Research Center, , Medical University of Graz, ; Graz, Austria
                [8 ]ISNI 0000 0004 0437 5432, GRID grid.1022.1, School of Medical Science and Menzies Health Institute of QLD, , Griffith Health, Griffith University, ; Southport, Australia
                [9 ]ISNI 0000 0004 1936 7830, GRID grid.29980.3a, Department of Human Nutrition, , University of Otago, ; Dunedin, New Zealand
                [10 ]ISNI 0000 0004 1936 8542, GRID grid.6571.5, School of Sport, Exercise and Health Sciences, , Loughborough University, ; Loughborough, UK
                [11 ]ISNI 0000 0004 0385 7472, GRID grid.1039.b, Research Institute for Sport and Exercise, , University of Canberra, ; Canberra, ACT 2617 Australia
                [12 ]WGI, Lewisville, TX USA
                [13 ]ISNI 0000 0000 9075 106X, GRID grid.254567.7, UofSC Sport Science Lab, Department of Exercise Science, , University of South Carolina, ; Columbia, SC USA
                [14 ]ISNI 0000 0001 1034 1720, GRID grid.410711.2, Applied Physiology Laboratory, Department of Exercise and Sport Science, , University of North Carolina, ; Chapel Hill, NC USA
                [15 ]ISNI 0000 0004 4687 2082, GRID grid.264756.4, Exercise & Sport Nutrition Lab, Human Clinical Research Facility, Department of Health & Kinesiology, , Texas A&M University, ; College Station, TX USA
                [16 ]ISNI 0000 0001 2353 285X, GRID grid.170693.a, Performance & Physique Enhancement Laboratory, , University of South Florida, ; Tampa, FL USA
                [17 ]Institute of Performance Nutrition, London, UK
                [18 ]Fitbiomics, Inc, New York, NY USA
                [19 ]Jamieson Wellness Inc, Windsor, Ontario Canada
                [20 ]Bioloab Research, Novara, Italy
                [21 ]Scientific Affairs. Nutrasource Diagnostics, Inc. Guelph, Guelph, Ontario Canada
                [22 ]ISNI 0000 0004 0368 0654, GRID grid.4425.7, Research Institute for Sport and Exercise Sciences, , Liverpool John Moores University, ; Tom Reilly Building, Byrom St Campus, Liverpool, UK
                [23 ]International Probiotic Association, Los Angeles, CA USA
                [24 ]ISNI 0000 0001 2168 8324, GRID grid.261241.2, Exercise and Sport Science, , Nova Southeastern University, ; Davie, FL USA
                Author information
                http://orcid.org/0000-0002-7345-9635
                Article
                329
                10.1186/s12970-019-0329-0
                6925426
                31864419
                ef4b5d4e-fb7a-442a-8a89-d2992edc9724
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 18 November 2019
                : 4 December 2019
                Categories
                Review
                Custom metadata
                © The Author(s) 2019

                Sports medicine
                gut-muscle-axis,microbiome,microbiota,sport performance,muscle
                Sports medicine
                gut-muscle-axis, microbiome, microbiota, sport performance, muscle

                Comments

                Comment on this article